Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b002122f91d2c6c2b12ebcc4fe3ee31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2099febd7c9ca4a9b2e5c5291f7be40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab26fbe7ff961f1ba4d348d5b4d25f27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b2b250d3f776665fc10408a3fc94c37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9737a80aa299f37fe899ecb1e3af3202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ab5d8af1c568987290d88ccdbe1010 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 |
filingDate |
2011-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99763a398921af4a0e7b639c4c6b8b91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc74404f4c519f445a72c6570e1fde6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601e86779f71ed25ef251f53f598090f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eae87a9fcb560af619a984baca918d99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_570b5b9ae299f7c46e09dce53cb1bf81 |
publicationDate |
2011-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011100209-A2 |
titleOfInvention |
Magnetically sensitive drug carriers for treatment or targeted delivery |
abstract |
Compositions of matter comprising a magnetically sensitive drug carrier and a related drug as well as methods for administering these compositions and causing them to localize within the patient using an internal or external magnetic field are described. |
priorityDate |
2010-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |